The NeurologyLive multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.
May 24, 2022
Video
The assistant professor of neurology at The Ohio State University Wexner Medical Center provided insight on finding strategies to prevent neurodegeneration in multiple sclerosis. [WATCH TIME: 3 minutes]
May 23, 2022
Article
Here's what is coming soon to NeurologyLive®.
May 22, 2022
Article
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuropathic disorders.
May 20, 2022
Article
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 20, 2022.
May 17, 2022
Article
The importance of addressing disorders of the brain cannot be overstated, and doing so will be essential to our generation and generations to come.
May 16, 2022
Article
Here's what is coming soon to NeurologyLive®.
May 15, 2022
Article
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.
May 14, 2022
Video
Neurology News Network for the week ending May 14, 2022. [WATCH TIME: 4 minutes]
May 13, 2022
Article
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 13, 2022.
May 13, 2022
Video
Barry A. Hendin, MD, discusses innate and adaptive immunity and BTK inhibitors in the treatment of multiple sclerosis (MS).
The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley
American Stroke Association Publishes Updated Guidance for Intracerebral Hemorrhage
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine
Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD